Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Older skin has higher cancer risk due to inflammation and stem cell issues.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Fat cells are important for tissue repair and stem cell support in various body parts.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Researchers found four genes that could help diagnose severe alopecia areata early.

Belatacept may be a promising treatment for alopecia areata.

Stem cells in the hair follicle are regulated by their surrounding environment, which is important for hair growth.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

MC-1R is present in skin cells and may help reduce inflammation.

Combining immune checkpoint inhibitors with other cancer therapies increases skin side effects in Asian patients.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Special cells can help regrow hair in alopecia areata.

CD2 might be a new treatment target for patchy alopecia areata.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

The circadian clock is crucial for tissue renewal and regeneration, affecting stem cell functions and having implications for health and disease.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Nerve cells and other cell types work together to start horn growth in dairy goats.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Hair follicles prevent NK cell attacks to avoid hair loss.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

The niche environment controls stem cell behavior and plasticity, which is important for tissue health and repair.

Abnormal ECM and immune cell interactions can cause skin diseases.